Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Other Non-Current Assets (2020 - 2025)

SOPHiA GENETICS's Other Non-Current Assets history spans 6 years, with the latest figure at $8.2 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 42.02% to $8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.2 million, a 42.02% increase, with the full-year FY2025 number at $8.2 million, up 42.02% from a year prior.
  • Other Non-Current Assets hit $8.2 million in Q4 2025 for SOPHiA GENETICS, up from $6.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SOPH hit a ceiling of $8.2 million in Q4 2025 and a floor of $2.2 million in Q2 2021.
  • Historically, Other Non-Current Assets has averaged $5.1 million across 5 years, with a median of $5.8 million in 2024.
  • Biggest five-year swings in Other Non-Current Assets: soared 148.99% in 2021 and later dropped 6.65% in 2025.
  • Tracing SOPH's Other Non-Current Assets over 5 years: stood at $3.7 million in 2021, then rose by 15.76% to $4.3 million in 2022, then soared by 42.42% to $6.1 million in 2023, then dropped by 5.54% to $5.8 million in 2024, then surged by 42.02% to $8.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for SOPH at $8.2 million in Q4 2025, $6.0 million in Q3 2025, and $6.6 million in Q2 2025.